Medical Disclaimer: This data is for informational purposes only. Success rates are influenced by patient age, diagnosis, and treatment type. Do not use this data alone to choose a fertility clinic. Consult a board-certified reproductive endocrinologist.

CDC NASS 2022 494 ART cycles California

Kindbody-San Francisco

Kindbody-San Francisco reported a 36.8% overall live-birth rate across 494 ART cycles in San Francisco, California (CDC NASS 2022).

San Francisco, California · ZIP 94104 · Last reported: 2022

Clinic verdict · CDC NASS 2022

Kindbody-San Francisco's IVF live-birth rate for patients under 35 is 46.4%, 2 points below the national average of 48%. Compare it across age groups and against the state below, and remember age is the strongest driver of IVF success.

36.8% Overall live birth
46.4% Under 35
494 Cycles, 2022
48% National, under 35

Where Kindbody-San Francisco sits among U.S. clinics

Overall CDC live-birth-rate band, 406 reporting clinics

Total Cycles

494

Reported 2022

Overall Success Rate

36.8%

Live births per cycle

+7.8pp vs CA avg

Rate Under 35

46.4%

Peak fertility cohort

Single Embryo Transfer

46.4%

ASRM-aligned safety metric

SET adherence vs national reference

Single-embryo-transfer rate is an ASRM-aligned safety metric, higher SET reduces multi-pregnancy and OHSS risk.

Kindbody-San Francisco SET rate 46.4%
78% national reference

Share of transfers using one embryo only

Success Rates by Age Group

Using own eggs (fresh + frozen cycles). The CDC reports patients over 40 in two separate brackets, 41–42 and 43+, shown here individually rather than combined.

Under 35 46.4%
35–37 30.6%
38–40 34.8%
41–42 Not reported
43+ Not reported

Success rate = live births per ART cycle started. Source: CDC NASS 2022.

Cycle Breakdown

Total Cycles
494
Fresh Cycles
10
Frozen Cycles
484
Years Reporting
3
Single Embryo Transfer %
46.4%

Services Available

  • Donor Egg Available
  • Gestational Carrier
California State Average
29.0%
View all 91 clinics in California →

What the CDC NASS Data Shows for Kindbody-San Francisco

Kindbody-San Francisco reported cycle outcomes to the CDC National ART Surveillance System for the 2022 reporting year, with 3 years of cumulative reporting history. The clinic performed 494 total ART cycles, split between 10 fresh and 484 frozen embryo transfer cycles. The overall success rate, live births per cycle started, was 36.8%. That is 7.8 percentage points above the California state average of 29.0%.

Age remains the dominant variable in IVF outcomes. At Kindbody-San Francisco, patients under 35 saw a 46.4% success rate, compared with 30.6% for ages 35–37 and 34.8% for ages 38–40. Single embryo transfer (SET) was used in 46.4% of cycles, a metric ASRM associates with lower multi-pregnancy rates.

Service availability also affects which clinics fit which patients. Kindbody-San Francisco does report donor egg services and does offer gestational carrier (surrogate) cycles. These services matter for patients with diminished ovarian reserve, same-sex couples, or medical conditions that preclude carrying a pregnancy. Every figure above is a public federal disclosure, not editorial commentary, PlainFertility is not affiliated with Kindbody-San Francisco or the CDC, and these statistics are not a substitute for an evaluation by a board-certified reproductive endocrinologist who can assess your individual diagnosis, history, and treatment options.

Read these figures as a starting point, not a verdict. The CDC reports live births per intended egg retrieval, so the percentages already account for cycles that never reached embryo transfer, a more conservative measure than the per-transfer pregnancy rates clinics sometimes advertise. Group results describe what happened for past patients; they cannot predict an individual outcome, which depends on diagnosis, ovarian reserve, sperm quality, embryo genetics, and the protocol a physician recommends. A single reporting year can swing for lower-volume clinics, so cumulative multi-year results and a candid consultation carry more weight than any one published number.

Historical Success Rates

Year Total Cycles Overall Under 35 35–37 38–40 41–42
2022 494 36.8% 46.4% 30.6% 34.8% N/A
2021 382 N/A N/A N/A N/A N/A
2020 159 N/A N/A N/A N/A N/A

Frequently Asked Questions

Kindbody-San Francisco's IVF success rate

Kindbody-San Francisco reports an overall IVF success rate of 36.8% across 494 reported cycles. Rates by age group vary, patients under 35 generally see higher success rates.

How should I interpret these success rates?

IVF success rates depend on patient age, diagnosis, embryo type, and treatment protocol. A clinic with a lower success rate may treat more complex cases. Always consult a board-certified reproductive endocrinologist who can evaluate your individual situation.

Where does this data come from?

All data is sourced from the CDC's National ART Surveillance System (NASS), which requires all ART clinics in the US to report their cycle outcomes annually under the Fertility Clinic Success Rate and Certification Act of 1992.

What is the difference between fresh and frozen IVF cycles?

Fresh cycles use embryos that have not been frozen, eggs are retrieved, fertilized, and transferred within the same treatment cycle. Frozen cycles use previously cryopreserved embryos. Kindbody-San Francisco reported 10 fresh cycles and 484 frozen cycles. Many clinics now favor frozen embryo transfers (FET) due to improved vitrification technology and comparable or higher success rates.

What does single embryo transfer (SET) percentage mean?

Single embryo transfer percentage indicates how often a clinic transfers just one embryo per cycle rather than multiple embryos. A higher SET rate generally reflects adherence to current ASRM guidelines aimed at reducing multiple pregnancies. Kindbody-San Francisco reports a SET rate of 46.4%. Higher SET rates typically mean fewer twins and triplets, which reduces pregnancy complications.

Does this clinic offer donor egg or gestational carrier services?

Kindbody-San Francisco does offer donor egg services and does offer gestational carrier (surrogate) services per the latest CDC NASS report. Contact the clinic directly to confirm current service availability and discuss whether these options are appropriate for your treatment plan.

Data source: CDC National ART Surveillance System (NASS). PlainFertility is not affiliated with the CDC or this clinic.

Data sourced from the CDC National ART Surveillance System (NASS). See our methodology for details. Retrieved and formatted by PlainFertility Editorial

Every figure on PlainFertility is rendered directly from CDC National ART Surveillance System source data, no number is typed in by an editor. This page draws directly on CDC National ART Surveillance System source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.